Description
CagriSema Blend 3mg/3mg from Polaris Peptides is a lyophilised research peptide with over 99% purity confirmed by HPLC-MS. CagriSema is a amylin analogue + GLP-1 receptor agonist blend (also known as CagriSema), supplied vacuum-sealed and sold strictly for laboratory research.
At $50.00 this vial works out to $8.33 per milligram. It is the smallest size we stock, which makes it a good fit for pilot experiments, method development or a first look at the compound.
What Is CagriSema Blend 3mg/3mg?
This vial combines equal amounts of cagrilintide, a long-acting amylin analogue, and semaglutide, a long-acting GLP-1 receptor agonist. In the literature this pairing is called CagriSema. Both peptides carry fatty acid modifications for albumin binding, so their activity windows line up well in research models.
The idea behind the combination is that amylin and GLP-1 work through different receptors in the brainstem and hypothalamus. Supplying both in one pre-measured vial saves researchers from weighing and mixing two lyophilised powders, which cuts handling error when running combination arms.
CagriSema Blend 3mg/3mg Specifications
| Product | CagriSema Blend 3mg/3mg |
|---|---|
| Compound | Cagrilintide / Semaglutide Blend |
| Also known as | CagriSema |
| Class | Amylin analogue + GLP-1 receptor agonist blend |
| Amount | 3mg/3mg |
| Form | Lyophilised powder |
| Purity | >99% (HPLC-MS) |
| Packaging | Vacuum-sealed |
| Storage | −20 °C dry; 2–8 °C once reconstituted |
| SKU | PLCS3 |
CagriSema Research Areas
Published studies on CagriSema cover several areas. The list below summarises the main ones so you can see where it fits your work.
- Complementary satiety pathways: amylin receptor and GLP-1 receptor signalling studied together.
- Combination versus monotherapy: comparing the blend against semaglutide or cagrilintide alone.
- Gastric emptying: how two slowing mechanisms interact in animal models.
- Metabolic endpoints: glucose, insulin and body-weight measures in obesity models.
Storing and Handling CagriSema Blend 3mg/3mg
Store unopened vials at −20 °C, where the dry powder stays stable for long periods. Before reconstitution, let the vial reach room temperature to stop condensation forming inside. Add bacteriostatic water or another lab-grade solvent slowly down the side of the vial and swirl gently rather than shaking. Once reconstituted, keep it at 2–8 °C and complete your work within 28 days.
Why Order CagriSema From Polaris Peptides
Every batch of CagriSema we sell is checked by HPLC-MS for identity and purity before it is listed. Vials are vacuum-sealed to keep moisture out and labelled with the exact amount. If you are comparing suppliers, ask for the batch analysis and check it against the label. That is the standard we hold ourselves to.
How CagriSema Blend 3mg/3mg Is Tested
We use two methods together. High-performance liquid chromatography (HPLC) separates the contents of a sample so we can see how much of it is the target compound and how much is anything else, such as truncated sequences or leftover synthesis reagents. Mass spectrometry (MS) then weighs the molecules, which confirms that the main peak really is CagriSema and not a look-alike. A result above 99% on both counts is what earns a batch a place in our catalogue. Lots that fall short are not sold.
Related Research Peptides
CagriSema is also available in other sizes: Cagrilintide 10mg, Semaglutide 10mg Blend.
Researchers working with CagriSema Blend 3mg/3mg often look at Cagrilintide 5mg, Semaglutide 10mg, Tirzepatide 5mg, Retatrutide 5mg. Browse the full GLP-1 & GIP Analogues collection or our Peptide Blends, or see every compound in the peptide shop.
CagriSema Blend 3mg/3mg FAQ
What ratio is in the CagriSema blend?
Both our blends are 1:1. You can choose 3mg cagrilintide with 3mg semaglutide, or 10mg of each.
Why buy a blend instead of two separate vials?
A pre-combined vial removes a weighing and mixing step, which keeps the ratio consistent from one experiment to the next.
What purity is CagriSema Blend 3mg/3mg?
Over 99%, confirmed by HPLC-MS on every batch.
How should CagriSema be stored?
Dry powder at −20 °C. After reconstitution, 2–8 °C, used within 28 days.
Is CagriSema Blend 3mg/3mg for human use?
No. It is sold for laboratory and in-vitro research only. It is not a drug, food or cosmetic and is not for human or veterinary use.
References
Read the published research on CagriSema at PubMed (U.S. National Library of Medicine).
For laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease. These statements have not been evaluated by the FDA.
Reviews
There are no reviews yet.